FindTrial
Sign In

Study to assess the effect of constitutional homoeopathic treatment on facial pigmentation (melasma) in women aged 20-45 years

A clinical study on constitutional homoeopathic medicine in the management of melasma in females aged 20-45 years, assessed by the mMASI scale - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101092
Enrollment
30
Registered
2026-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

Intervention1: Constitutional homoeopathic intervention: This is a single-arm clinical study conducted to evaluate the effectiveness of constitutional homoeopathic treatment in patients with melasma.

Sponsors

Parul Institute of Homoeopathy and Research Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed cases of melasma, aged between 20 and 45 years, and not under any concurrent treatment for melasma (allopathic, ayurvedic, or cosmetic).

Exclusion criteria

Exclusion criteria: Pregnant or lactating women; patients with systemic diseases such as thyroid disorders, liver disorders, or polycystic ovarian syndrome (PCOS) contributing to melasma, patients who have received steroid creams, chemical peels, or laser therapy for melasma in the last 3 months.

Design outcomes

Primary

MeasureTime frame
To measure the improvement in mMASI score before and after constitutional homoeopathic treatment.Timepoint: 3 Months—

Secondary

MeasureTime frame
To evaluate the role of constitutional homoeopathic treatment in the management of melasma.Timepoint: 3 Months—

Countries

India

Contacts

Public ContactDr. Shivani Panchal

Parul Institute of Homoeopathy and Research

mamta.tapas87086@paruluniversity.ac.in9604287095

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026